Abbott Laboratories will buy Piramal Healthcare Ltd.�"s branded generic-medicine unit in India for $3.72 billion, becoming the country�"s biggest drugmaker and tapping into a market expected to more than double by 2015....
Read More...
[Source: BusinessWeek.com -- ]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment